Nifty 18210.95 (-0.31%)
Sensex 61143.33 (-0.34%)
Nifty Bank 40874.35 (-0.88%)
Nifty IT 35503.9 (0.97%)
Nifty Financial Services 19504.75 (-0.74%)
Adani Ports 745.85 (-0.54%)
Asian Paints 3094.65 (4.20%)
Axis Bank 787.50 (-6.46%)
B P C L 427.70 (-0.78%)
Bajaj Auto 3776.50 (-0.40%)
Bajaj Finance 7482.15 (-4.75%)
Bajaj Finserv 18012.00 (-1.86%)
Bharti Airtel 702.35 (0.88%)
Britannia Inds. 3697.85 (0.14%)
Cipla 922.50 (1.65%)
Coal India 173.60 (-0.83%)
Divis Lab. 5149.35 (2.60%)
Dr Reddys Labs 4662.70 (-0.08%)
Eicher Motors 2583.90 (-0.25%)
Grasim Inds 1728.40 (-0.63%)
H D F C 2915.00 (0.12%)
HCL Technologies 1177.15 (0.89%)
HDFC Bank 1642.80 (-0.60%)
HDFC Life Insur. 693.85 (0.55%)
Hero Motocorp 2690.15 (-0.38%)
Hind. Unilever 2396.60 (-1.65%)
Hindalco Inds. 479.85 (-1.28%)
I O C L 130.80 (-0.53%)
ICICI Bank 835.00 (0.68%)
IndusInd Bank 1142.55 (-1.07%)
Infosys 1728.95 (1.48%)
ITC 238.45 (0.74%)
JSW Steel 684.90 (-1.36%)
Kotak Mah. Bank 2188.25 (-1.03%)
Larsen & Toubro 1784.55 (-0.65%)
M & M 886.80 (-0.87%)
Maruti Suzuki 7356.25 (0.81%)
Nestle India 19004.60 (-1.11%)
NTPC 141.30 (-1.33%)
O N G C 157.90 (-3.19%)
Power Grid Corpn 190.25 (-0.08%)
Reliance Industr 2627.40 (-1.26%)
SBI Life Insuran 1186.00 (1.19%)
Shree Cement 28107.75 (1.19%)
St Bk of India 519.15 (1.29%)
Sun Pharma.Inds. 825.10 (1.43%)
Tata Consumer 818.75 (1.22%)
Tata Motors 497.90 (-2.11%)
Tata Steel 1326.15 (-1.30%)
TCS 3489.75 (0.21%)
Tech Mahindra 1567.85 (0.29%)
Titan Company 2460.10 (0.22%)
UltraTech Cem. 7354.20 (1.17%)
UPL 741.50 (3.96%)
Wipro 671.10 (0.44%)

Companies where MF have the highest exposure

Mutual Fund Exposure
by 5paisa Research Team 29/09/2021

Read on to find the companies where mutual funds have the highest exposure.  

The fund managers of the mutual funds are considered to be smart investors. And therefore many investors tend to follow them. To know the companies where the mutual fund managers have the highest exposure, we analysed the portfolio of the open-ended equity dedicated mutual fund along with aggressive hybrid mutual funds for the month ending August 2021. We excluded variants of the same fund to remove the duplicity.  sma

At the end of August 2021, mutual funds (equity dedicated and aggressive allocation hybrid fund) have exposure to 800 unique equities. Their combined investment values in these equities are Rs 15.73 lakh crore. Nevertheless, it is the top 30 companies that account for 50% of the investment values. Further analysis shows that large-cap companies account for 64% of total investment value, mid-cap companies account for 24% and small-cap companies’ account for the balance 12% of total investment value.  

Among large-cap stocks, ICICI Bank is most widely held by mutual funds with 6% of total investment value. It is followed by HDFC Bank and Infosys that hold 5% and 4% of total investment value respectively. Surprisingly Reliance Industry does not feature in the top five holdings.  

Mutual Fund Holdings in Top 5 Large Cap Stocks 

Company  

Investment (Rs Cr)  

% of Total Investment  

Cap  

ICICI Bank Ltd  

87,968.88  

5.59%  

Large Cap  

HDFC Bank Ltd  

77,178.97  

4.90%  

Large Cap  

Infosys Ltd  

70,190.65  

4.46%  

Large Cap  

Bharti Airtel Ltd  

45,573.43  

2.90%  

Large Cap  

State Bank of India  

44,196.18  

2.81%  

Large Cap  

 

Mutual Fund Holdings in Top 5 Mid Cap Stocks 

 

Company  

Investment (Rs Cr)  

% of Total Investment  

Cap  

Bharat Electronics Ltd  

10,391.53  

0.66%  

Mid Cap  

Crompton Greaves Consumer Electricals Ltd  

10,045.36  

0.64%  

Mid Cap  

Voltas Ltd  

9,322.63  

0.59%  

Mid Cap  

Max Financial Services Ltd  

8,696.33  

0.55%  

Mid Cap  

Mphasis Ltd  

8,160.73  

0.52%  

Mid Cap  

 

Mutual Fund Holdings in Top 5 Small Cap Stocks 

 

Company  

Investment (Rs Cr)  

% of Total Investment  

Cap  

Carborundum Universal Ltd  

3,873.11  

0.25%  

Small Cap  

SKF India Ltd  

3,797.69  

0.24%  

Small Cap  

Cholamandalam Financial Holdings Ltd  

3,236.84  

0.21%  

Small Cap  

Indian Energy Exchange Ltd  

3,045.40  

0.19%  

Small Cap  

PNC Infratech Ltd  

2,684.56  

0.17%  

Small Cap  

 
Read More: Small Cap Stocks to Watch on September 30

 

Next Article

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
There is some issue, try later
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order

5 Stocks to Buy Today: September 30, 2021

5 Stocks to Buy Today
by 5paisa Research Team 29/09/2021

Every morning our analysts scan through the markets universe and chose the best momentum stocks to buy today. The stocks are recommended from a wider list of momentum stocks and only the best ones make it to the top 5 list. We also update on the performance of earlier recommendation every morning to help you with your trading journey. Read on to know the momentum stocks to buy today. The average holding period could be between 7-10 days on average.

List of 5 Stocks to Buy Today

1. Indian Energy (IEX)

Indian Energy Stock Details for Today

- Current Market Price: Rs.637

- Stop Loss: Rs. 620

- Target 1: Rs. 655

- Target 2: Rs. 673

- Holding Period: One week

5paisa Recommendation: Our technical experts see a strong volume in the stock hence making this stock best stock to buy.

 

2. IRB Infrastructure (IRB)

IRB Infrastructure Stock Details for Today: 

- Current Market Price: Rs. 190

- Stop Loss: Rs. 184

- Target 1: Rs. 197

- Target 2: Rs. 204

- Holding Period: 1 week

5paisa Recommendation: Our technical analysts observe positive chart structure, thus recommending this stock as the best stock to buy today. 

 

3. TATA Chemicals (TATACHEM)

TATA Chemicals Stock Details for Today: 

- Current Market Price: Rs. 933

- Stop Loss: Rs. 905

- Target 1: Rs.965

- Target 2: Rs. 1,000

- Holding Period: 1 week

5paisa Recommendation: Momentum in stock is expected and thus making this stock as one of the best stocks to buy today.

 

4. HEG Ltd (HEG)

HEG Ltd Stock Details for Today: 

- Current Market Price: Rs. 2,313

- Stop Loss: Rs. 2,270

- Target 1: Rs. 2,3175

- Target 2: Rs. 2,450

- Holding Period: 1 week

5paisa Recommendation: Our technical experts expects further buying in the stock and recommends buying this stock.

 

5. Ajanta Pharma (AJANTPHARM)

Ajanta Pharma Stock Details for Today: 

- Current Market Price: Rs. 2,301

- Stop Loss: Rs. 2,250

- Target 1: Rs. 2,350

- Target 1: Rs. 2,415

- Holding Period: 1 week

5paisa Recommendation: Our technical experts see end in sideways move of the stock hence making this stock best stock to buy.

 

Share Market Today

SGX NIFTY: 

SGX Nifty indicates flat to negative opening for Indian markets.SGX Nifty is at 17,691.20 levels, lower 19.15 points. (Updated at 7:46 AM).

International Markets:

US Market:

US markets ended mixed with Dow Jones gaining 90 points while Nasdaq closed with losses of 34 points even as the Russell 2000 index closed in the red.

Bond yields closed slightly lower at 1.51% while the US$ index closed at 6-month highs at 94.34 which sees emerging markets under pressure.

 

Asian Market:

Asian markets opened in the red like the Japanese 'Nikkei' traded lower by 150 points in early trade, while the Taiwan and South Korean markets also were under pressure as technology stocks saw selling pressure.

Chinese stocks have been seeing selling as fresh money enters other Asian markets with Indian equities seeing maximum interest.
 

Disclaimer: The above report is compiled from information available on the public platforms.

Next Article

Veeda Clinical Research files DRHP for Rs 831 crore IPO. Find out more

by 5paisa Research Team 30/09/2021

Veeda Clinical Research Ltd has filed a draft red herring prospectus (DRHP) with the capital markets regulator Securities and Exchange Board of India to launch an initial public offering (IPO).

The clinical research company’s IPO will consist of a fresh issue of shares worth up to Rs 331.60 crore and an offer for sale of Rs 500 crore by its promoters and investors.

The company’s promoter, Basil Pvt. Ltd, will sell shares worth Rs 141.93 crore. Other selling shareholders include Bondway Investment Inc., which is offloading shares worth Rs 259.77 crore, Arabelle Financial Services Ltd (Rs 90.19 crore) and private equity firm CX Partners.

The company intends to use the fresh capital to repay debt, fund its capex, finance acquisitions by its subsidiary Bioneeds, fund its working capital requirements and meet expenses towards general corporate purposes.

The IPO filing comes a few months after the Ahmedabad-based company raised about Rs 118 crore from PE firm Sabre Partners and several affluent individuals, including Pranab Mody of JB Chemicals, Nikhil Vora of Sixth Sense Ventures, Arjun Bhartia of Jubilant Group as well as Havells India’s family office.

Veeda Clinical’s business and financials

The company is one of the largest independent full-service clinical research organisations (CRO) in India in terms of revenue, according to a Frost & Sullivan report.

It offers a broad range of services across most aspects of the drug development and drug-launch value chain throughout global markets, including North America, Europe and Asia. The company specialises in the focused segment of Bio Availability/Bio Equivalence (BA/BE) studies.

The company has grown from a single facility in 2004 to four facilities today and has the capability to process 1 lakh samples per month.

As of March 2021, Veeda had conducted more than 3,500 trials and developed more than 1,000 bio-analytical methods across generics. It has also completed 85 global inspections with regulatory authorities such as the US Food and Drug Administration, the UK’s Medicines and Healthcare products Regulatory Agency, and the World Health Organization.

In 2020-21, it completed studies for 157 clients. Some of its prominent customers include Dr Reddy’s Labs, Mankind Pharma, Granules India and Novugen Pharma.

To support its capabilities and offer clinical services for novel drugs, Veeda acquired a 50.1% stake in Bengaluru-based Bioneeds India. It had acquired a minority stake in the company between March and July 2021.

The company’s consolidated revenue from operations stood at Rs 195.81 crore for the year ended March 2021. This is down from Rs 218.44 crore for 2018-19.

Its profit after tax for 2020-21 came in at Rs 62.97 crore, up from Rs 44.16 crore two years before.

Next Article

Tanla Platforms set to seal more partnerships as stock on upward trajectory

by 5paisa Research Team 30/09/2021

Tanla Platforms, a mid-cap technology company which enables businesses to communicate with their customers and stakeholders via cloud-based platforms, is going to announce two significant partnerships on its Wisely platform.

Wisely is a communication platform-as-a-service (CPaaS) that offers a digital marketplace for enterprises and suppliers. Tanla expects to launch Wisely globally in the first quarter of 2022.

Senior Tanla executives said at IIFL’s Invest India Virtual Conference that the company would leverage one of these partnerships to expand its footprint in conversational platforms and OTT (over the top) channels.

“Though we see some increase in competitive intensity in the Indian CPaaS space going forward, a favourable mix change towards the higher-margin platforms business should support overall margin in our view,” according to a note by IIFL Securities.

Outlook for Tanla Platforms

IIFL Securities has a ‘buy’ rating on the stock and forecasts 23% compound annual growth rate for earnings per share from 2020-21 through 2022-23. It also said that the stock looks attractive at a one-year forward price-to-earnings ratio of 22.4x.

The brokerage firm has a 12-month target price of Rs 1,121 a share on the company as against its current market price of around Rs 838 apiece. This means there is a potential upside of over 33%.

The company's share price has oscillated between a low of Rs 267 and a high of Rs 1,030 during the past year. 

The company closed 2020-21 with revenue of Rs 2,341.5 crore and a net profit of Rs 356 crore. It is projected to expand its operating margins from 18.5% to over 21% by 2023-24.

According to IIFL, the company would more than double its revenue in four years from Rs 1,942.8 crore in 2019-20 with the EBITDA margin also rising more than two-fold in the same period.

What’s driving Tanla’s business?

Tanla recently expanded its bouquet of services by acquiring Karix, the market leader in the Indian CPaaS space, and Gamooga, a marketing automation company, in 2019-20. It also recently launched Trubloq, a blockchain-based solution to filter spam text messages. Trubloq processes 62% of India’s SMS traffic.

Karix is estimated to have around 30% market share in the business, around the same as its three nearest peers ACL Mobile, Gupshup and ValueFirst combined.

Tanla has been working on driving partnerships, and even though it is yet to give further details on the two upcoming partnerships, IIFL believes these could add an extra leg to growth.

Wisely has been witnessing significant traction in India and Microsoft was already announced as the go-to-market partner for Wisely at launch. A large consulting firm is working with Tanla on the Wisely strategy to serve global markets and the CPaaS offering is expected to be rolled out fully in the next six months.

Tanla sees its addressable market growing at over 20% with existing Indian CPaaS market growing by 15% annually and the entry of new-age companies in ad-tech, ed-tech, fintech and gaming topping it up with an additional 5%.

The multiple use-cases of Trubloq and the above opportunities in conversational platforms and OTT channels would further expand the addressable market. The international opportunity will be in addition to these.

Separately, Tanla is building a 92,000 sq ft Innovation and Experience Centre in Hyderabad that is also likely to be operational by March. The centre would develop and showcase technologies and platforms to customers and partners.

Next Article

Superstar stocks for October 01, 2021

Superstar stocks for October 01,2021
by 5paisa Research Team 30/09/2021

Looking for stocks that could deliver good returns till tomorrow, meet the superstar stocks for tomorrow which are selected based on a three-factor model.

Many times market participants see a stock opening with a gap-up and wish they should have bought this superstar stock a day before to take advantage of the gap-up move.To fulfil this wish, we have come out with a unique system, which would help us to get the list of candidates that can be probable superstar stocks for tomorrow.

The superstar stocks for tomorrow are selected based on a three-factor prudent model. The first important factor for this model is price, the second key factor is pattern, and last but not least is the combination of momentum with volume. If a stock passes all these filters it would flash in our system and as a result, it will help traders to spot the superstar stocks for tomorrow at the right time!

Here are the superstar stocks for October 01,2021.

Aditya Birla Fashion and Retail (ABFRL):The stock of ABFRL has hit a fresh 52-week high on Thursday and it has witnessed a breakout of horizontal trendline. Moreover, the breakout has been seen on the back of a huge spurt in the volume. The volume has already witnessed a threefold jump when compared to its previous trading session. The RSI on the daily time frame has marked a fresh 14-period high and it’s in bullish territory. Meanwhile, on the weekly and hourly time as well RSI is in bullish territory. Given the fact that the stock has witnessed breakout along with above-average volume, the stock can probably test levels of Rs 257-258 on the upside, while on the downside, support is seen around Rs 240.  

Dixon Technologies:The stock of Dixon Technologies is seen outperforming the benchmark indices as it has gained nearly 2%. The stock has seen a good spike in the volume in the last one hour of trade along with a price rise.The volumes for the day have already surpassed its previous day volume. The RSI has marked a fresh 14-period on the daily time frame and moreover, it is above the 60-mark and in a rising trajectory. On the weekly time frame as well, RSI is above 60 and on the hourly time frame as well it's above 60. The stock has the potential to test its previous high which is placed around levels of Rs 4735.On the downside, the level of Rs 4450 is likely to act as immediate support for the stock.

Amber Enterprises:The stock has formed a strong bullish candle and it has seen its best gains for a single day for a long time. Interestingly, more than 50% of the volume for the day has been seen during the last one hour of trade. Overall, the volume for the day has already surpassed its previous day volume. The RSI is in the bullish territory on the hourly, daily and weekly time frame.The stock has the potential to test levels of Rs 3450 and immediate support for the stock is placed at Rs 3150

Next Article

Consistent wealth creation: A Saurabh Mukherjea mantra

Stocks can be bought despite the high price and high valuation if it is a master franchise, an explanation by Saurabh Mukherjea.
by 5paisa Research Team 30/09/2021

Stocks can be bought despite the high price and high valuation if it is a master franchise, an explanation by Saurabh Mukherjea.

Extremely bullish on a master franchise.

 

Saurabh’s view on the last decade of the Indian market has been this whole Diamonds in the Dust story. Just to put some numbers around it, over the last 10 years, the Indian stock market has created USD 1 trillion of wealth. That’s huge but 80 per cent of that one trillion has come from 16 stocks. Another way to think about it is that today we have reached a situation in India where 10 master franchises or 10 diamonds account for 90-95 per cent of the nation’s profit.

For instance, in IT services, giants like TCS can keep attrition down to a single digit whereas everybody else is struggling to keep attrition down even to 15 per cent. This story will play out in India wherein every sector, one or two franchises are taking away 90 per cent of the profits.

Strategy for a long-term double-digit return.

Suppose someone bought a champion compounder like Asian Paints at the year’s low, every year for the last 10 years. They would have compounded the return around 27-28 per cent, it is a great outcome. But practically speaking, someone did SIP, say on January 1 every year. If they did that every year for 10 years in a row, they would have made around 26 per cent, still a very good outcome. But, unfortunately, if they buy Asian Paints at the years’ high,10 years in a row, they will still compound at 19 per cent.

Therefore, the point here is, if one locks into a champion franchise where the underlying business compounds at 20-25 per cent, it does not matter whether one buys it at the years’ high or the year’s low. One will compound broadly at that 25 per cent. There are 15 to 20 such companies in the country and one should be locking into these master franchises. They will be the core, the key to wealth creation in India over the next decade.

Saurabh Mukherjea is the founder and CIO of Marcellus Investment Managers, where they offer three different investment strategies such as Consistent compounders PMS, Little Champs PMS, Kings of capital PMS.

He has more than 20 years of industry experience, where he was rated as the leading equity strategist from 2015 – 2017 by Asiamoney polls.He has authored several best-selling books to name a few,Coffee Can Investing (2018), The Victory Project (2020),and Diamonds in the Dust is the recent release (2021)